Last reviewed · How we verify

NCT06761781

Augmented Reality for Stroke Rehabilitation

Completed NA Last updated 25 April 2025
What this trial tests

NA trial testing Augmented Reality in Stroke/Brain Attack in 70 participants. Completed in 30 March 2025.

Timeline
31 December 2024
Primary endpoint
30 March 2025
30 March 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment70
Start date31 December 2024
Primary completion30 March 2025
Estimated completion30 March 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 90, any sex, with Stroke/Brain Attack. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to determine the effectiveness of Augmented reality on motor function, balance, and functional ambulation in stroke patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Augmented Reality

Trials testing the same drug.

Other recruiting trials for Stroke/Brain Attack

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing